Bryan Johnson & Kate Tolo On Curing Their Incurable Diseases, Addressing The Disparity In Women's Health & The Don't Die Mission

What It Covers

Bryan Johnson and Kate Tolo discuss their simultaneous diagnoses with incurable diseases — Johnson with autoimmune gastritis and Tolo with endometriosis — while detailing a $2.6 million female health quantification protocol measuring 1,900 biomarkers across 100 days, the systemic failures in women's medical diagnosis, induced pluripotent stem cell banking, and the philosophical framework underlying the Don't Die mission.

Key Questions Answered

• •Endometriosis Diagnosis Gap: Women with endometriosis wait an average of six and a half years to receive a diagnosis because surgery has historically been the only confirmation method. Tolo received her diagnosis in 42 days by combining four modalities: an endometriosis-specific transvaginal ultrasound, an endometriosis-protocol MRI, a blood test, and a saliva test. Women suspecting endometriosis should request endo-specific imaging protocols, as standard ultrasounds and MRIs routinely return false negatives for this condition.
• •Female Biomarker Variability: Cholesterol levels in women can fluctuate up to 19% between the first and second halves of the menstrual cycle, meaning roughly 6% of women test falsely high when drawn at the wrong cycle point. Approximately half of 400 measured blood metabolites fluctuate across the cycle, yet reference ranges remain unstandardized for cycle phase. Women should inform their physician of their cycle day when getting blood drawn to avoid misinterpretation of results.
• •Sleep Optimization — Five Rules: Johnson outlines five evidence-based habits to lower resting heart rate before bed, which he frames as the single most accessible longevity marker. The rules are: no food within four hours of bedtime, screens off 30 minutes before sleep, a wind-down routine of reading or walking, avoiding white and blue light in favor of red and amber, and cutting caffeine by noon. A consistent pre-sleep wind-down routine is described as equivalent in effect to sleep medication.
• •Resting Heart Rate as a Unified Health Metric: For people without access to complex testing, tracking resting heart rate before bed functions as a composite readout of the day's inputs — food timing, alcohol, stress, light exposure, and screen use. When resting heart rate is elevated, sleep quality degrades, willpower decreases the following day, and healthy behaviors become harder to sustain. This single metric creates a feedback loop that either reinforces or undermines all other health behaviors.
• •Induced Pluripotent Stem Cell Banking: Johnson extracted 150 milliliters of blood, isolated cells, and applied Yamanaka factors to epigenetically reverse their age to zero, creating a personal bank of embryonic-like stem cells. These iPSCs can later be used to rebuild diseased tissue — such as stomach lining in autoimmune gastritis — using the patient's own cells, eliminating rejection risk. Ongoing clinical trials are already using patient-derived iPSCs for Parkinson's disease and heart failure, making this a near-term medical application.
• •N-of-1 Female Health Research as Population-Level Entry Point: Because women's menstrual cycles make group-level clinical trials logistically difficult — ovulation timing varies widely, with many women ovulating around day 17 to 23 rather than the assumed day 14 — individual intensive self-tracking may be the most viable path to generating population-level insights. Tolo's protocol, measuring daily hormones via urine, vaginal microbiome, breast size, metabolic rate, and cortisol, is designed to establish a Rosetta Stone of female biomarker fluctuation that can later inform scalable trial design.
• •Immune System Sequencing for Autoimmune Conditions: Johnson had one million immune cells individually profiled to identify cell type, function, and receptor specificity, then took 24 stomach biopsies under general anesthesia to grow a tissue culture. Combining immune cell sequencing with live biopsy cultures allows researchers to match specific immune cell populations to the tissue they are attacking, enabling targeted therapy selection. Johnson describes this combined approach as previously undone and completed within a four-week window.